PharmacoEconomics
Collection
Collection
- ISSN: 11707690
- https://link.springer.com/journal/40273
Published by ADI BV
-
Unrelated medical costs in life-years gained: Should they be included in economic evaluations of healthcare interventions? Note
D.R. Rappange (David), P.H.M. van Baal (Pieter), N.J.A. van Exel (Job), T.L. Feenstra (Talitha), F.F.H. Rutten (Frans) and W.B.F. Brouwer (Werner)
September 2008 -
Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland An analysis of the EUROPA study including 1251 Polish patients Article
PharmacoEconomics, 26(10), 861-877.W.K. Redekop (Ken), E. Orlewska (Ewa), P. Maciejewski (Pawel), F.F.H. Rutten (Frans) and L.W. Niessen (Louis Wilhelmus)
September 2008 -
Preferences of GPs and patients for preventive osteoporosis drug treatment: A discrete-choice experiment Article
PharmacoEconomics, 27(3), 211-219.E.W. de Bekker-Grob (Esther), M.L.E. Essink-Bot (Marie-Louise), W.J. Meerding (Willem Jan), B.W. Koes (Bart) and E.W. Steyerberg (Ewout)
April 2009 -
Holistic preferences for 1-year health profiles describing fluctuations in health: the case of chronic obstructive pulmonary disease Article
PharmacoEconomics, 27(6), 465-477.M.P.M.H. Rutten-van Mölken (Maureen) and M. Hoogendoorn (Martine)
August 2009 -
Healthcare costs and obesity prevention: drug costs and other sector-specific consequences Article
PharmacoEconomics, 27(12), 1031-1044.December 2009 -
Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding Article
PharmacoEconomics, 28(3), 217-230.A.N. Barkun (Alan), V. Adam (Viviane), J.J.Y. Sung (Joseph), E.J. Kuipers (Ernst), J. Mössner (Joachim), D.M. Jensen (Dennis), R. Stuart (Robert), J.Y.W. Lau (James), E. Nauclér (Emma), J. Kilhamn (Jan), et al. H. Granstedt (Helena), B. Liljas (Bengt) and T. Lind (Tore)
February 2010 -
Does the inclusion of a cost attribute result in different preferences for the surgical treatment of primary basal cell carcinoma?: A comparison of two discrete-choice experiments Article
PharmacoEconomics, 28(6), 507-520.B.A.B. Essers (Brigitte), D. van Helvoort-Postulart (Debby), M.H. Prins (Martin), H.A.M. Neumann (Martino) and C.D. Dirksen (Carmen)
May 2010 -
Comparing methods of data synthesis: Re-estimating parameters of an existing probabilistic cost-effectiveness model Article
PharmacoEconomics, 29(3), 239-250.M. Oppe (Mark), M.J. Al (Maiwenn) and M.P.M.H. Rutten-van Mölken (Maureen)
February 2011